The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
Open accessAbstract
Aldehyde dehydrogenase (ALDH) is a superfamily of enzymes that detoxify a variety of endogenous and exogenous aldehydes and are required for the biosynthesis of retinoic acid (RA) and other molecular regulators of cellular function. Over the past decade, high ALDH activity has been increasingly used as a selectable marker for normal cell populations enriched in stem and progenitor cells, as well as for cell populations from cancer tissues enriched in tumor-initiating stem-like cells. Mounting evidence suggests that ALDH not only may be used as a marker for stem cells but also may well regulate cellular functions related to self-renewal, expansion, differentiation, and resistance to drugs and radiation. ALDH exerts its functional actions partly through RA biosynthesis, as all-trans RA reverses the functional effects of pharmacological inhibition or genetic suppression of ALDH activity in many cell types in vitro. There is substantial evidence to suggest that the role of ALDH as a stem cell marker comes down to the specific isoform(s) expressed in a particular tissue. Much emphasis has been placed on the ALDH1A1 and ALDH1A3 members of the ALDH1 family of cytosolic enzymes required for RA biosynthesis. ALDH1A1 and ALDH1A3 regulate cellular function in both normal stem cells and tumor-initiating stem-like cells, promoting tumor growth and resistance to drugs and radiation. An improved understanding of the molecular mechanisms by which ALDH regulates cellular function will likely open new avenues in many fields, especially in tissue regeneration and oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280 · cited 1×
“SP cells from various types of tissues have been associated with self-renewal and multilineage differentiation capacity [8, 9].”
BackgroundIntrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., & Melton, D. A. (2002) · Science · doi:10.1126/science.1072530 · Cited by 1,709
A Stem Cell Molecular Signature
Ivanova, N. B., Dimos, J. T., Schaniel, C., Hackney, J. A., Moore, K. A., & Lemischka, I. R. (2002) · Science · doi:10.1126/science.1073823 · Cited by 1,542
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Fillmore, C. M., & Kuperwasser, C. (2008) · Breast Cancer Research · doi:10.1186/bcr1982 · Cited by 1,033
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Shi, J., & Vakoc, C. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.016 · Cited by 878
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
Marchitti, S. A., Brocker, C., Stagos, D., & Vasiliou, V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.697 · Cited by 805
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1630 · Cited by 732
Mao, P., Joshi, K., Li, J., Kim, S.-H., Li, P., Santana-Santos, L., Luthra, S., Chandran, U. R., Benos, P. V., Smith, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221478110 · Cited by 642
Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
Singh, S., Brocker, C., Koppaka, V., Chen, Y., Jackson, B. C., Matsumoto, A., Thompson, D. C., & Vasiliou, V. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.010 · Cited by 601
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Tomita, H., Tanaka, K., Tanaka, T., & Hara, A. (2016) · Oncotarget · doi:10.18632/oncotarget.6920 · Cited by 595
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002428 · Cited by 589
Tanei, T., Morimoto, K., Shimazu, K., Kim, S. J., Tanji, Y., Taguchi, T., Tamaki, Y., & Noguchi, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1479 · Cited by 574
Storms, R. W., Trujillo, A. P., Springer, J. B., Shah, L., Colvin, O. M., Ludeman, S. M., & Smith, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9118 · Cited by 551
eRNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription
Melo, C. A., Drost, J., Wijchers, P. J., van de Werken, H., de Wit, E., Vrielink, J. A. F. O., Elkon, R., Melo, S. A., Léveillé, N., Kalluri, R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.11.021 · Cited by 544
The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
Ma, I., & Allan, A. L. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9208-4 · Cited by 539
Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
Marcato, P., Dean, C. A., Giacomantonio, C. A., & Lee, P. W. K. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15486 · Cited by 516
Marcato, P., Dean, C. A., Pan, D., Araslanova, R., Gillis, M., Joshi, M., Helyer, L., Pan, L., Leidal, A., Gujar, S., et al. (2011) · Stem Cells · doi:10.1002/stem.563 · Cited by 483
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
Lawenda, B. D., Kelly, K. M., Ladas, E. J., Sagar, S. M., Vickers, A., & Blumberg, J. B. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn148 · Cited by 472
Chute, J. P., Muramoto, G. G., Whitesides, J., Colvin, M., Safi, R., Chao, N. J., & McDonnell, D. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603806103 · Cited by 467
Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
Ma, S., Chan, K. W., Lee, T. K.-W., Tang, K. H., Wo, J. Y.-H., Zheng, B.-J., & Guan, X.-Y. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0035 · Cited by 459
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Rasheed, Z. A., Yang, J., Wang, Q., Kowalski, J., Freed, I., Murter, C., Hong, S.-M., Koorstra, J.-B., Rajeshkumar, N. V., He, X., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp535 · Cited by 437
Sullivan, J. P., Spinola, M., Dodge, M., Raso, M. G., Behrens, C., Gao, B., Schuster, K., Shao, C., Larsen, J. E., Sullivan, L. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0881 · Cited by 416
Kim, M., Turnquist, H. R., Jackson, J. D., Sgagias, M. K., Yan, Y., Gong, M., Dean, M. C., Sharp, J. G., & Cowan, K. H. (2002) · PubMed · Cited by 397
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Landen, C. N., Goodman, B., Katre, A. A., Steg, A. D., Nick, A. M., Stone, R. L., Miller, L. D., Mejia, P. V., Jennings, N. B., Gershenson, D. M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0563 · Cited by 382
Li, T., Su, Y., Mei, Y., Leng, Q., Leng, B., Liu, Z., Stass, S. A., & Jiang, F. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.127 · Cited by 362
Update on the aldehyde dehydrogenase gene (ALDH) superfamily
Jackson, B., Brocker, C., Thompson, D. C., Black, W., Vasiliou, K., Nebert, D. W., & Vasiliou, V. (2011) · Human Genomics · doi:10.1186/1479-7364-5-4-283 · Cited by 356
Hess, D. A., Meyerrose, T. E., Wirthlin, L., Craft, T. P., Herrbrich, P. E., Creer, M. H., & Nolta, J. A. (2004) · Blood · doi:10.1182/blood-2004-02-0448 · Cited by 351
Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
Mueller, M., Hermann, P. C., Witthauer, J., Rubio–Viqueira, B., Leicht, S. F., Huber, S., Ellwart, J. W., Mustafa, M., Bartenstein, P., D'Haese, J. G., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.053 · Cited by 348
Zhao, D., McCaffery, P., Ivins, K. J., Neve, R. L., Hogan, P., Chin, W. W., & Dräger, U. C. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0015h.x · Cited by 344
Assessment of aldehyde dehydrogenase in viable cells
Jones, R., Barber, J., Vala, M., Collector, M., Kaufmann, S., Ludeman, S., Colvin, O., & Hilton, J. (1995) · Blood · doi:10.1182/blood.v85.10.2742.bloodjournal85102742 · Cited by 333
Fortunel, N. O., Otu, H. H., Ng, H.-H., Chen, J., Mu, X., Chevassut, T., Li, X., Joseph, M., Bailey, C., Hatzfeld, J. A., et al. (2003) · Science · doi:10.1126/science.1086384 · Cited by 332
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells
Kastan, M., Schlaffer, E., Russo, J., Colvin, O., Civin, C., & Hilton, J. (1990) · Blood · doi:10.1182/blood.v75.10.1947.1947 · Cited by 307
Raha, D., Wilson, T. R., Peng, J., Peterson, D., Yue, P., Evangelista, M., Wilson, C., Merchant, M., & Settleman, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3456 · Cited by 307
Poised epigenetic states and acquired drug resistance in cancer
Brown, R., Curry, E., Magnani, L., Wilhelm-Benartzi, C. S., & Borley, J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3819 · Cited by 301 · cited 1×
“Mounting evidence suggests that epigenetic regulation of stem cell-related genes is involved in drug resistance [145].”
BackgroundAldehyde dehydrogenases and cell proliferation
Muzio, G., Maggiora, M., Paiuzzi, E., Oraldi, M., & Canuto, R. A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.033 · Cited by 297
Rovira, M., Scott, S.-G., Liss, A. S., Jensen, J., Thayer, S. P., & Leach, S. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912589107 · Cited by 290
Hess, D. A., Wirthlin, L., Craft, T. P., Herrbrich, P. E., Hohm, S. A., Lahey, R., Eades, W. C., Creer, M. H., & Nolta, J. A. (2006) · Blood · doi:10.1182/blood-2005-06-2284 · Cited by 287
Differential Expression of Novel Potential Regulators in Hematopoietic Stem Cells
Forsberg, E. C., Prohaska, S. S., Katzman, S., Heffner, G. C., Stuart, J. M., & Weissman, I. L. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010028 · Cited by 285
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
Luo, Y., Dallaglio, K., Chen, Y., Robinson, W. A., Robinson, S. E., McCarter, M. D., Wang, J., Gonzalez, R., Thompson, D. C., Norris, D. A., et al. (2012) · Stem Cells · doi:10.1002/stem.1193 · Cited by 281
Corti, S., Locatelli, F., Papadimitriou, D., Donadoni, C., Salani, S., Del Bo, R., Strazzer, S., Bresolin, N., & Comi, G. P. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0217 · Cited by 280
Jimeno, A., Feldmann, G., Suárez-Gauthier, A., Rasheed, Z., Solomon, A., Zou, G.-M., Rubio-Viqueira, B., García-García, E., López-Ríos, F., Matsui, W., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0924 · Cited by 276
Aldehyde Dehydrogenase as a Marker for Stem Cells
Moreb, J. (2008) · Current Stem Cell Research & Therapy · doi:10.2174/157488808786734006 · Cited by 272
Lenburg, M. E., Liou, L. S., Gerry, N. P., Frampton, G. M., Cohen, H. T., & Christman, M. F. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-31 · Cited by 269
Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
Ross-Innes, C. S., Stark, R., Holmes, K. A., Schmidt, D., Spyrou, C., Russell, R., Massie, C. E., Vowler, S. L., Eldridge, M., & Carroll, J. S. (2010) · Genes & Development · doi:10.1101/gad.552910 · Cited by 260
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer
Magni, M., Shammah, S., Schiro, R., Mellado, W., Dalla-Favera, R., & Gianni, A. (1996) · Blood · doi:10.1182/blood.v87.3.1097.bloodjournal8731097 · Cited by 251
Duester, G., Mic, F. A., & Molotkov, A. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00204-1 · Cited by 243
Hartley, D. P., Ruth, J. A., & Petersen, D. R. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1028 · Cited by 241
Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses
Yoon, K.-A., Nakamura, Y., & Arakawa, H. (2004) · Journal of Human Genetics · doi:10.1007/s10038-003-0122-3 · Cited by 234
Morimoto, K., Kim, S. J., Tanei, T., Shimazu, K., Tanji, Y., Taguchi, T., Tamaki, Y., Terada, N., & Noguchi, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01151.x · Cited by 227
Cheung, A. M. S., Wan, T. S. K., Leung, J. C. K., Chan, L. Y. Y., Huang, H., Kwong, Y. L., Liang, R., & Leung, A. Y. H. (2007) · Leukemia · doi:10.1038/sj.leu.2404721 · Cited by 226
Cojoc, M., Peitzsch, C., Kurth, I., Trautmann, F., Kunz-Schughart, L. A., Telegeev, G. D., Stakhovsky, E. A., Walker, J. R., Simin, K., Lyle, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1924 · Cited by 223
A clinically relevant population of leukemic CD34+CD38− cells in acute myeloid leukemia
Gerber, J. M., Smith, B. D., Ngwang, B., Zhang, H., Vala, M. S., Morsberger, L., Galkin, S., Collector, M. I., Perkins, B., Levis, M. J., et al. (2012) · Blood · doi:10.1182/blood-2011-06-364182 · Cited by 222
Retinoid signaling regulates breast cancer stem cell differentiation
Ginestier, C., Wicinski, J., Cervera, N., Monville, F., Finetti, P., Bertucci, F., Wicha, M. S., Birnbaum, D., & Charafe-Jauffret, E. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9761 · Cited by 217
Sládek, N. E., Kollander, R., Sreerama, L., & Kiang, D. T. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0412-4 · Cited by 212
The Role of CD44 and Cancer Stem Cells
Wang, L., Zuo, X., Xie, K., & Wei, D. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7401-6_3 · Cited by 206
Stem Cells Are Units of Natural Selection in a Colonial Ascidian
Laird, D. J., De Tomaso, A. W., & Weissman, I. L. (2005) · Cell · doi:10.1016/j.cell.2005.10.026 · Cited by 205
Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition
Ying, M., Wang, S., Sang, Y., Sun, P., Lal, B., Goodwin, C. R., Guerrero-Cazares, H., Quinones-Hinojosa, A., Laterra, J., & Xia, S. (2011) · Oncogene · doi:10.1038/onc.2011.58 · Cited by 204
Duru, N., Fan, M., Candas, D., Menaa, C., Liu, H.-C., Nantajit, D., Wen, Y., Xiao, K., Eldridge, A., Chromy, B. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1436 · Cited by 204
Aldehyde dehydrogenases and cancer stem cells
Xu, X., Chai, S., Wang, P., Zhang, C., Yang, Y., Yang, Y., & Wang, K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.018 · Cited by 204
Moreb, J. S., Ucar, D., Han, S., Amory, J. K., Goldstein, A. S., Ostmark, B., & Chang, L.-J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.10.007 · Cited by 203
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Januchowski, R., Wojtowicz, K., & Zabel, M. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.04.005 · Cited by 202
Properties of a Fetal Multipotent Neural Stem Cell (NEP Cell)
Cai, J., Wu, Y., Mirua, T., Pierce, J. L., Lucero, M. T., Albertine, K. H., Spangrude, G. J., & Rao, M. S. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0828 · Cited by 188
Masiá, S., Alvarez, S., de Lera, A. R., & Barettino, D. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0062 · Cited by 184
Moreb, J. S., Baker, H. V., Chang, L., Amaya, M. J., López, M. C., Ostmark, B., & Chou, W. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-87 · Cited by 178
Membrane properties of rat embryonic multipotent neural stem cells
Cai, J., Cheng, A., Luo, Y., Lu, C., Mattson, M. P., Rao, M. S., & Furukawa, K. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02184.x · Cited by 176
Wakamatsu, Y., Sakamoto, N., Oo, H. Z., Naito, Y., Uraoka, N., Anami, K., Sentani, K., Oue, N., & Yasui, W. (2012) · Pathology International · doi:10.1111/j.1440-1827.2011.02760.x · Cited by 175
Schug, T. T., Berry, D. C., Toshkov, I. A., Cheng, L., Nikitin, A. Y., & Noy, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709981105 · Cited by 172
Cai, J., Weiss, M. L., & Rao, M. S. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.03.013 · Cited by 167
Capoccia, B. J., Robson, D. L., Levac, K. D., Maxwell, D. J., Hohm, S. A., Neelamkavil, M. J., Bell, G. I., Xenocostas, A., Link, D. C., Piwnica-Worms, D., et al. (2009) · Blood · doi:10.1182/blood-2008-04-154567 · Cited by 166
NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells
Zhao, D., Mo, Y., Li, M.-T., Zou, S.-W., Cheng, Z.-L., Sun, Y.-P., Xiong, Y., Guan, K.-L., & Lei, Q.-Y. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76611 · Cited by 164
Kitahara, O., Katagiri, T., Tsunoda, T., Harima, Y., & Nakamura, Y. (2002) · Neoplasia · doi:10.1038/sj.neo.7900251 · Cited by 163
Awad, O., Yustein, J. T., Shah, P., Gul, N., Katuri, V., O'Neill, A., Kong, Y., Brown, M. L., Toretsky, J. A., & Loeb, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013943 · Cited by 163
Shao, C., Sullivan, J. P., Girard, L., Augustyn, A., Yenerall, P., Rodriguez-Canales, J., Liu, H., Behrens, C., Shay, J. W., Wistuba, I. I., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3292 · Cited by 159
Hirata, N., Yamada, S., Shoda, T., Kurihara, M., Sekino, Y., & Kanda, Y. (2014) · Nature Communications · doi:10.1038/ncomms5806 · Cited by 152
Burger, P. E., Gupta, R., Xiong, X., Ontiveros, C. S., Salm, S. N., Moscatelli, D., & Wilson, E. L. (2009) · Stem Cells · doi:10.1002/stem.135 · Cited by 152
Marcato, P., Dean, C. A., Liu, R., Coyle, K. M., Bydoun, M., Wallace, M., Clements, D. R., Turner, C., Mathenge, E. G., Gujar, S. A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.010 · Cited by 152
Honoki (2010) · Oncology Reports · doi:10.3892/or_00000885 · Cited by 151
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
Rodriguez-Torres, M., & Allan, A. L. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9755-9 · Cited by 150
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
Yokoyama, Y., Zhu, H., Lee, J., Kossenkov, A. V., Wu, S. Y., Wickramasinghe, J. M., Yin, X., Palozola, K. C., Gardini, A., Showe, L. C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0854 · Cited by 144
Corti, S. P., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Ronchi, D., Saladino, F., Bordoni, A., Fortunato, F., Bo, R. D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35432 · Cited by 142
Storms, R. W., Green, P. D., Safford, K. M., Niedzwiecki, D., Cogle, C. R., Colvin, O. M., Chao, N. J. A., Rice, H. E., & Smith, C. A. (2005) · Blood · doi:10.1182/blood-2004-09-3652 · Cited by 132
Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
Alison, M. R., Guppy, N., Lim, S. M. L., & Nicholson, L. J. (2010) · The Journal of Pathology · doi:10.1002/path.2772 · Cited by 131
Potential mechanisms of CD133 in cancer stem cells
Jang, J.-W., Song, Y., Kim, S.-H., Kim, J., & Seo, H. R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.008 · Cited by 126
Blocking the formation of radiation-induced breast cancer stem cells
Wang, Y., Li, W., Patel, S. S., Cong, J., Zhang, N., Sabbatino, F., Liu, X., Qi, Y., Huang, P., Lee, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1992 · Cited by 119
Moreb, J. S., Muhoczy, D., Ostmark, B., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0233-6 · Cited by 118
Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
Orywal, K., & Szmitkowski, M. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0408-3 · Cited by 118
Selection of Tumorigenic Melanoma Cells Using ALDH
Boonyaratanakornkit, J. B., Yue, L., Strachan, L. R., Scalapino, K. J., LeBoit, P. E., Lü, Y., Leong, S. P. L., Smith, J. E., & Ghadially, R. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.237 · Cited by 116
Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?
Pors, K., & Moreb, J. S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.009 · Cited by 113
Levi, B. P., Yilmaz, Ö. H., Duester, G., & Morrison, S. J. (2008) · Blood · doi:10.1182/blood-2008-05-156752 · Cited by 113
Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer
Chen, Y., Orlicky, D. J., Matsumoto, A., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.002 · Cited by 111
Elizondo, G., Corchero, J., Sterneck, E., & Gonzalez, F. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004987200 · Cited by 111
Direct Interaction of All-trans-retinoic Acid with Protein Kinase C (PKC)
Radomińska‐Pandya, A., Chen, G., Czernik, P. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907722199 · Cited by 111
Kim, Y., Yoon, H. Y., Kim, J. S., Kang, H. W., Min, B.-D., Kim, S., Ha, Y., Kim, I. Y., Ryu, K. H., Lee, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28121 · Cited by 110
HNF4α reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma
Lucas, B., Grigo, K. N. C., Erdmann, S., Lausen, J., Klein‐Hitpaß, L., & Ryffel, G. U. (2005) · Oncogene · doi:10.1038/sj.onc.1208794 · Cited by 109
The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
van den Hoogen, C., van der Horst, G., Cheung, H., Buijs, J. T., Pelger, R. C. M., & van der Pluijm, G. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9395-7 · Cited by 109
Kuroda, T., Hirohashi, Y., Torigoe, T., Yasuda, K., Takahashi, A., Asanuma, H., Morita, R., Mariya, T., Asano, T., Mizuuchi, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065158 · Cited by 107
Liu, J., Xiao, Z., Wong, S. K., Tin, V. P., Ho, K.-Y., Wang, J., Sham, M. H., & Wong, M. P. (2013) · Oncotarget · doi:10.18632/oncotarget.1246 · Cited by 100
Ran, D., Schubert, M., Pietsch, L., Taubert, I., Wuchter, P., Eckstein, V., Bruckner, T. M., Zoeller, M., & Ho, A. D. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.10.001 · Cited by 100
Prasmickaite, L., Engesæter, B. Ø., Skrbo, N., Hellenes, T., Kristian, A., Oliver, N. K., Suo, Z., & Mælandsmo, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010731 · Cited by 97
Mizuno, T., Suzuki, N., Makino, H., Furui, T., Morii, E., Aoki, H., Kunisada, T., Yano, M., Kuji, S., Hirashima, Y., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.005 · Cited by 96
Christ, O., Lücke, K., Imren, S., Leung, K., Hamilton, M. J., Eaves, A. C., Smith, C. A., & Eaves, C. J. (2007) · Haematologica · doi:10.3324/haematol.11366 · Cited by 95
Moreb, J. S., Gabr, A., Vartikar, G. R., Gowda, S., Zucali, J. R., & Mohuczy, D. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072496 · Cited by 93
Cancer stem cells: Models, mechanisms and implications for improved treatment
Zhou, J., & Zhang, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5953 · Cited by 92
Aldehyde Dehydrogenase Activity Is a Biomarker of Primitive Normal Human Mammary Luminal Cells
Eirew, P. D., Kannan, N., Knapp, D. J. H. F., Vaillant, F., Emerman, J. T., Lindeman, G. J., Visvader, J. E., & Eaves, C. J. (2011) · Stem Cells · doi:10.1002/stem.1001 · Cited by 92
Corti, S. P., Locatelli, F., Papadimitriou, D. A., Donadoni, C., Bo, R. D., Crimi, M., Bordoni, A., Fortunato, F., Strazzer, S., Menozzi, G., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi446 · Cited by 92
Kim, R., Park, J.-R., Roh, K., Choi, A.-R., Kim, S., Kim, P.-H., Yu, J. H., Lee, J. W., Ahn, S. H., Gong, G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.026 · Cited by 92
Vauchez, K., Marolleau, J., Schmid, M., Khattar, P., Chapel, A., Catelain, C., Lecourt, S., Larghero, J., Fiszman, M. Y., & Vilquin, J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.204 · Cited by 91
Povsic, T. J., Zavodni, K. L., Kelly, F. L., Zhu, S., Goldschmidt‐Clermont, P. J., Dong, C., & Peterson, E. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.033 · Cited by 89
Mu, X., Isaac, C. E., Greco, N., Huard, J., & Weiss, K. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00143 · Cited by 87
Singh, S. P., Arcaroli, J. J., Chen, Y., Thompson, D. C., Messersmith, W. A., Jimeno, A., & Vasiliou, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121648 · Cited by 84
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Kozovská, Z., Patsalias, A., Bajzik, V., Durinikova, E., Demková, L., Jargasova, S., Smolková, B., Plavá, J., Kučerová, L., & Matúšková, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4572-6 · Cited by 83
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer
Li, X.-S., Xu, Q. R., Fu, X., & Luo, W. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-705 · Cited by 82
A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations
Canino, C., Luo, Y., Marcato, P., Blandino, G., Pass, H. I., & Cioce, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3703 · Cited by 80
Transcription Factor Oct1 Is a Somatic and Cancer Stem Cell Determinant
Maddox, J., Shakya, A., South, S., Shelton, D. N., Andersen, J. N., Chidester, S., Kang, J., Gligorich, K. M., Jones, D. A., Spangrude, G. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003048 · Cited by 79
Pearce, D. J., & Bonnet, D. A. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.06.002 · Cited by 78
Retinoic acid receptors, hematopoiesis and leukemogenesis
Collins, S. J. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283007edf · Cited by 77
Inhibition of Aldehyde Dehydrogenase Expands Hematopoietic Stem Cells with Radioprotective Capacity
Muramoto, G. G., Russell, J. L., Safi, R., Salter, A. B., Himburg, H. A., Daher, P., Meadows, S. K., Doan, P. L., Storms, R. W., Chao, N. J. A., et al. (2010) · Stem Cells · doi:10.1002/stem.299 · Cited by 76
Rexer, B. N., Zheng, W. L., & Ong, D. E. (2001) · PubMed · Cited by 75
Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells
Jean, E., Laoudj‐Chenivesse, D., Notarnicola, C., Rouger, K., Serratrice, N., Bonnieu, A., Gay, S., Bacou, F., Duret, C., & Carnac, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00942.x · Cited by 73
Huddle, B. C., Grimley, E. C., Buchman, C. D., Chtcherbinine, M., Debnath, B., Mehta, P., Yang, K., Morgan, C. A., Li, S., Felton, J. A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00930 · Cited by 72
Marchitti, S. A., Brocker, C. N., Orlicky, D. J., & Vasiliou, V. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.004 · Cited by 71
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
Yang, Y., Zhou, W. H., Xia, J., Gu, Z., Wendlandt, E. B., Zhan, X., Janz, S., Tricot, G. J. K., & Zhan, F. (2014) · Oncotarget · doi:10.18632/oncotarget.2388 · Cited by 71
The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair
Koninckx, R., Daniëls, A., Windmolders, S., Mees, U., Mačianskienė, R., Mubagwa, K., Steels, P., Jamaer, L., Dubois, J., Robič, B., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs427 · Cited by 70
Appel, B., & Eisen, J. S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00688-3 · Cited by 69
Hoshino, Y., Nishida, J., Katsuno, Y., Koinuma, D., Aoki, T., Kokudo, N., Miyazono, K., & Ehata, S. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.011 · Cited by 69
He, X., Gonzalez-Pena, V., Tsang, A. H., Thompson, J., Tsang, T. C., & Harris, D. T. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.188 · Cited by 68
ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status
Feng, H., Liu, Y., Bian, X., Zhou, F., & Liu, Y. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.363 · Cited by 68
Zhang, W., Yan, W., You, G., Bao, Z., Wang, Y., Liu, Y., You, Y., & Jiang, T. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.033 · Cited by 65
Rosa, P. L., Bielli, P., Compagnucci, C., Cesari, E., Volpe, E., Vecchioli, S. F., & Sette, C. (2016) · eLife · doi:10.7554/elife.20750 · Cited by 64
Deng, Y., Zhou, J., Fang, L., Cai, Y., Ke, J., Xie, X., Huang, Y., Huang, M., & Wang, J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.767 · Cited by 62
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
Johansson, H. J., Sanchez, B. C., Mundt, F., Forshed, J., Kovács, A., Panizza, E., Hultin‐Rosenberg, L., Lundgren, B., Märtens, U., Máthé, G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3175 · Cited by 60
Successful Isolation of Liver Progenitor Cells by Aldehyde Dehydrogenase Activity in Na"ve Mice
Dollé, L., Best, J., Empsen, C., Mei, J., Rossen, E. V., Roelandt, P. R., Snykers, S., Najimi, M., Battah, F. A., Theise, N. D., et al. (2011) · Hepatology · doi:10.1002/hep.24693 · Cited by 59
Bunting, K. D., & Townsend, A. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11884 · Cited by 58
Burns, C. E., & Zon, L. I. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00329-5 · Cited by 58
Sullivan, K. E., Rojas, K., Cerione, R. A., Nakano, I., & Wilson, K. F. (2017) · Oncotarget · doi:10.18632/oncotarget.16479 · Cited by 57
Pérez‐Alea, M., McGrail, K., Sánchez‐Redondo, S., Fábrega, B. F., Fournet, G., Cortés, J., Muñoz‐Couselo, E., Hernández‐Losa, J., Tenbaum, S. P., Martin, G., et al. (2017) · Oncogene · doi:10.1038/onc.2017.160 · Cited by 57
The Transcriptional Regulation of Human Aldehyde Dehydrogenase I Gene
Yanagawa, Y., Chen, J. C., Hsu, L. C., & Yoshida, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17521 · Cited by 54
Sherman, S. E., Kuljanin, M., Cooper, T. T., Putman, D. M., Lajoie, G., & Hess, D. A. (2017) · Stem Cells · doi:10.1002/stem.2612 · Cited by 53
Trasino, S. E., Harrison, E. H., & Wang, T. T. Y. (2007) · PubMed · Cited by 51
Wang, Y., Zhe, H., Gao, P. H., Zhang, N., Li, G., & Qin, J. (2011) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2011.01279.x · Cited by 50
Perin, E. C., Murphy, M. P., March, K. L., Bolli, R., Loughran, J. H., Yang, P. C.-M., Leeper, N. J., Dalman, R. L., Alexander, J. Q., Henry, T. D., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.025707 · Cited by 50
Søndergaard, C. S., Hess, D. A., Maxwell, D. J., Weinheimer, C. J., Rosová, I., Creer, M. H., Piwnica-Worms, D. R., Kovács, A. D., Pedersen, L., & Nolta, J. A. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-24 · Cited by 49
Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance
Hida, K., Maishi, N., Akiyama, K., Ohmura‐Kakutani, H., Torii, C., Ohga, N., Osawa, T., Kikuchi, H., Morimoto, H., Morimoto, M., et al. (2017) · Cancer Science · doi:10.1111/cas.13388 · Cited by 48 · cited 2×
“ALDH endothelial cells resistant to fluorouracil in vitro and in vivo have been described in tumor vessels [110].”
BackgroundKaur, H., Mao, S., Li, Q., Sameni, M., Krawetz, S. A., Sloane, B. F., & Mattingly, R. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050249 · Cited by 47
Takebe, N., Zhao, S.-C., Adhikari, D., Mineishi, S., Sadelain, M., Hilton, J., Colvin, M., Banerjee, D., & Bertino, J. R. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0236 · Cited by 44
Obermair, F.-J., Fiorelli, R., Schroeter, A., Beyeler, S., Blatti, C., Zoerner, B., & Thallmair, M. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.05.001 · Cited by 42
Touma, S. E., Perner, S., Rubin, M. A., Nanus, D. M., & Gudas, L. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.022 · Cited by 40
Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
Ikeda, J.-I., Mamat, S., Tian, T., Wang, Y., Luo, W., Rahadiani, N., Aozasa, K., & Morii, E. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.4 · Cited by 37
Szabo, A. Z., Fong, S., Yue, L., Zhang, K., Strachan, L. R., Scalapino, K. J., Mancianti, M., & Ghadially, R. (2013) · Stem Cells · doi:10.1002/stem.1329 · Cited by 37
Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations
Povsic, T. J., Zavodni, K. L., Vainorius, E., Kherani, J. F., Goldschmidt‐Clermont, P. J., & Peterson, E. D. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.10.010 · Cited by 35
Yu, W. S., Jeong, S., Kim, J., Lee, H., Song, H. S., Kim, M., Ko, E., Lee, H., Khil, J., Jang, H.-J., et al. (2011) · Molecules and Cells · doi:10.1007/s10059-011-2254-1 · Cited by 34
Liu, C., Chen, B. J., Deoliveira, D., Sempowski, G. D., Chao, N. J. A., & Storms, R. W. (2010) · Blood · doi:10.1182/blood-2009-12-260810 · Cited by 29
Isolation of human hematopoietic stem cells.
Bernstein, I. D., Rg, A., & Rowley, S. D. (1994) · PubMed · Cited by 25
Sreerama, L., & Sládek, N. E. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00269-6 · Cited by 22
Identification of novel VHL targets that are associated with the development of renal cell carcinoma
Abdulrahman, M., Maina, E. N., Morris, M. R., Zatyka, M., Raval, R. R., Banks, R. E., Wiesener, M. S., Richards, F. M., Johnson, C. M., Latif, F., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209932 · Cited by 21
Kashii-Magaribuchi, K., Takeuchi, R., Haisa, Y., Sakamoto, A., Itoh, A., Izawa, Y., Isa, M., Fukuzawa, M., Murakami, M., & Takahashi, R. (2016) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.16031 · Cited by 15
Oakie, A., Li, J., Fellows, G. F., Hess, D. A., & Wang, R. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0135 · Cited by 6
Cited by
Cancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Gu, Y., Yang, R., Zhang, Y., Guo, M., Takehiro, K., Zhan, M., Yang, L., & Wang, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00239-2 · Cited by 184
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
Pizzimenti, S., Ribero, S., Cucci, M. A., Grattarola, M., Monge, C., Dianzani, C., Barrera, G., & Muzio, G. (2021) · Antioxidants · doi:10.3390/antiox10121942 · Cited by 79
Chen, Z., Ioris, R. M., Richardson, S., Van Ess, A. N., Vendrell, I., Kessler, B. M., Buffa, F. M., Busino, L., Clifford, S. C., Bullock, A. N., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00983-4 · Cited by 41
Metadata
- Authors
- Vassalli, G.
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2019-01-13
- Volume
- 2019
- Pages
- 1-15
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- OpenAlex
- W2909429444
- Cited by
- 300
- References
- 168
- FWCI
- 18.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.